Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis. [PDF]
Jaguszewski MJ +4 more
europepmc +1 more source
A Comment on the use of Levosimendan for the Management of Right Ventricular Dysfunction in Patients Undergoing Mitral Valve Surgery. [PDF]
Shah D, Korfiotis D, Zimbler N.
europepmc +1 more source
Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry. [PDF]
Codina P +7 more
europepmc +1 more source
Clinical and echocardiographic changes after intermittent levosimendan infusion in patients with advanced heart failure. [PDF]
Riccardi M +13 more
europepmc +1 more source
The possible impact of levosimendan infusions on clinical course of heart failure: the results of the LEIA-HF study. [PDF]
Kazimierczyk E +21 more
europepmc +1 more source
Impact of Pre-Heart Transplant Levosimendan Administration on Post-Transplant Vasoplegia and Primary Graft Dysfunction. [PDF]
Guzman-Bofarull J +9 more
europepmc +1 more source
Outpatient 6-Hour Levosimendan Treatment as a Bridge to Heart Transplant. [PDF]
Gonçalves AV +11 more
europepmc +1 more source
Intravenous Levosimendan versus Milrinone: Coronary Sinus Lactate and PA Catheter Derived Parameters in Patients with Pulmonary Hypertension Undergoing Elective Mitral Valve Replacement. [PDF]
Virmani S +6 more
europepmc +1 more source
Effects of levosimendan on occurrence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a case-control study. [PDF]
Trinh-Duc A +5 more
europepmc +1 more source
Lowering B-type natriuretic peptide levels and increasing cardiac function: the role of levosimendan in the treatment of heart failure. [PDF]
Meng J, Zuo Y.
europepmc +1 more source

